title: Psoriasiform skin eruption associated with sorafenib therapy.
authors.forename: Marcos A
authors.initials: MA
authors.lastname: González-López
authors.forename: M Carmen
authors.initials: MC
authors.lastname: González-Vela
authors.forename: Sonsoles
authors.initials: S
authors.lastname: Yáñez
authors.forename: Héctor
authors.initials: H
authors.lastname: Fernández-Llaca
authors.forename: J Fernando
authors.initials: JF
authors.lastname: Val-Bernal
mesh_terms: D001557:Benzenesulfonates / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D011565:Psoriasis / Q000139:chemically induced* / Q000175:diagnosis*; D011725:Pyridines / Q000009:adverse effects*; D000077157:Sorafenib
chemical_list: D001557:Benzenesulfonates; D010671:Phenylurea Compounds; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib